Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 clinical study of the innovative MesoC2 drug at the ASCO Annual Meeting, and ...

Roche RHHBY announced today that the FDA has approved a label expansion of ophthalmology drug Susvimo (ranibizumab injection). The regulatory body approved the drug Susvimo for the treatment of ...

In terms of performance, BSE has shown a return ... In the realm of technical analysis for our subject stock, the moving averages present a detailed picture. Over a short span of 5 days, the ...

In terms of performance, Larsen & Toubro has shown ... In the realm of technical analysis for our subject stock, the moving averages present a detailed picture. Over a short span of 5 days ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...